This bispecific anti-c-Met/anti-Her2 antibody in which the anti-Her2 scFv is fused at the C-terminus of the anti-c-Met antibody. It is capable of suppressing the cancer cell proliferation by inhibiting Her2 and c-Met activation as well as increasing anticancer effects by the internalization of c-Met and Her2 into the cells at the same time.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for TRIAB-MZ008. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.